Clinical Roundup Combination treatment may dramatically improve survival in brain cancer March 06, 2026Vol.52 No.09
Drugs & Targets FDA approves teclistamab + daratumumab hyaluronidase-fihj for r/r MM March 06, 2026Vol.52 No.09
Drugs & Targets FDA grants tentative approval for Lutetium Lu 177 dotatate March 06, 2026Vol.52 No.09
Drugs & Targets Keytruda + Padcev reduced risk of EFS and death for muscle-invasive bladder cancer when given before and after surgery March 06, 2026Vol.52 No.09
PodcastThe Directors The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.” February 27, 2026Vol.52 No.08By Claire Marie Porter and Paul Goldberg
Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE“Deidentified” ≠ “deidentifiable” February 27, 2026Vol.52 No.08By Paul Goldberg
Black History MonthPodcast Joni Nelson tells us how her background led her to pursue research that meets the needs of the community“I’m standing on the shoulders of giants” February 27, 2026Vol.52 No.08By Joni D. Nelson, Robert A. Winn and Preston Willett
Guest Editorial When radiology fails to fix clinical trial imaging workflow at sites…What most think, why it’s wrong, and what cancer centers really need February 27, 2026Vol.52 No.08By Jeff Sorenson
Cancer Policy USPSTF under threat of elimination, former members warn February 27, 2026Vol.52 No.08By Claire Marie Porter
